Myo-Inositol Trispyrophosphate (ITPP)

What is Myo-Inositol Trispyrophosphate (ITPP)? Myo-Inositol Trispyrophosphate (ITPP) is a synthetic pyrophosphorylated derivative of myo-inositol. Its structure is altered as it has three attached pyrophosphate groups that results in a membrane-permeable phosphorylated analog Researchers have found that this synthetic modification may allow ITPP to penetrate red blood cells and interact directly with hemoglobin. In different research models, Myo-Inositol Trispyrophosphate (ITPP) is being studied due to its potential effects on oxygen delivery and utilization in tissues. How Does Myo-Inositol Trispyrophosphate (ITPP) Work? Myo-Inositol Trispyrophosphate (ITPP) works in the following ways, as observed in different research models: 1. Hemoglobin & Oxygen Binding in Research Models Myo-Inositol Trispyrophosphate (ITPP) has been shown to help with hemoglobin and oxygen binding in research models. Researchers have observed that Hemoglobin (Hb) in red blood cells normally binds oxygen in the lungs and releases it in tissues in experimental models. The balance between holding oxygen vs. releasing it is known as oxygen affinity. Researchers have observed that when Hb affinity is too high, other tissues cannot get enough oxygen. Myo-Inositol Trispyrophosphate (ITPP) may help lower the Hb affinity, which ultimately helps oxygen to be released in the tissues of research subjects. 2. ITPP as an Allosteric Effector in Experimental Settings ITPP is a membrane-permeant derivative of inositol hexaphosphate (IHP). A few preliminary studies have suggested ITPP may bind allosterically to hemoglobin (meaning it attaches at a regulatory site, not the oxygen-binding site). This binding stabilizes hemoglobin in the deoxygenated (T-state) and lowers oxygen affinity in preclinical models. By lowering oxygen affinity, ITPP causes hemoglobin to release more oxygen in tissues, especially in areas of low oxygen (hypoxic tissues). Potential Benefits of Myo-Inositol Trispyrophosphate (ITPP) Myo-Inositol Trispyrophosphate (ITPP) is still under investigation; however, preliminary studies have shown its following potential benefits in research settings. May improve oxygen delivery in experimental models. Potentially enhances endurance in preliminary studies. Possibly reduce tumor hypoxia in preclinical models. Might support cardiac function in experimental settings. May protect brain tissue in preliminary studies. Potentially lessen hypoxia-related issues in preclinical models. Potential Side Effects of Myo-Inositol Trispyrophosphate (ITPP) The following are a few of the side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compounds. May cause alterations in hemoglobin function in experimental models. Potentially leads to unknown metabolic effects in preliminary studies. Possibly affect red blood cell stability in preclinical models. It might influence cardiovascular parameters in experimental settings. May trigger unforeseen immune reactions in preliminary studies. Potentially present long-term safety concerns in preclinical models. Why Buy Myo-Inositol Trispyrophosphate (ITPP) from Us? We provide high-quality, third-party tested Myo-Inositol Trispyrophosphate (ITPP) for your research. At Purerawz, we don’t compromise on the quality of our products. All our products go through stringent quality testing, including Myo-Inositol Trispyrophosphate (ITPP). This particular product is third-party verified and comes with a proper c ertificate of analysis (COA). Note: In the Nootropics Powder category, PureRawz offers lab-tested formulations including L-Theanine, Melatonin and many other product. FAQs What is the shelf life of Myo-Inositol Trispyrophosphate (ITPP)? The shelf life of Myo-Inositol Trispyrophosphate (ITPP) may depend on formulation and storage. However, in experimental settings, it has shown stability for extended periods when kept under controlled conditions. What is the half-life of Myo-Inositol Trispyrophosphate (ITPP)? In preclinical models, the half-life of Myo-Inositol Trispyrophosphate (ITPP) appears relatively short in because it is metabolized and cleared from circulation. How stable is Myo-Inositol Trispyrophosphate (ITPP)? ITPP is more stable than some natural inositol phosphates, particularly under laboratory conditions, according to experimental studies. Does Myo-Inositol Trispyrophosphate (ITPP) undergo degradation? Yes, ITPP may degrade over time or with improper storage, as noted in preliminary studies. Disclaimer This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Kindly verify information independently before purchasing. By ordering, you agree to our Terms and Conditions . If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use.